DB adds to Molnupiravir sponsorship
The DB Investment and Development One Member Company Ltd has sponsored an additional 1.1 million pills for the Ministry of Health’s pilot program on using Molnupiravir to treat F0 Covid-19 patients at home, bringing its total sponsorship to over 2 million pills.
